Hombeck Torsten
SEC insider (Form 3/4/5 filer). CIK 0001983682. CFO at Akari Therapeutics Plc (AKTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 20, 2025. Located in BOSTON, MA.
Companies Hombeck Torsten has filed insider reports for
- Akari Therapeutics Plc (AKTX): Officer, CFO
Hombeck Torsten
CIK: 0001983682
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTX
Akari Therapeutics Plc
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
300K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
200K shares- - Jan 10, 2025AKTX
Akari Therapeutics Plc
AwardDirect200 shares at avg. $1.22$244
1-3 of 3 transactions